- /
- Supported exchanges
- / US
- / PIII.NASDAQ
P3 Health Partners Inc (PIII NASDAQ) stock market data APIs
P3 Health Partners Inc Financial Data Overview
P3 Health Partners Inc., a patient-centered and physician-led population health management company, provides superior care services in the United States. The company operates clinics and wellness centers. P3 Health Partners Inc. was founded in 2020 and is based in Henderson, Nevada.
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with P3 Health Partners Inc (top by weight)
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Or get access to advanced financial data starting only $19.99
Get P3 Health Partners Inc data using free add-ons & libraries
Get P3 Health Partners Inc Fundamental Data
P3 Health Partners Inc Fundamental data includes:
- Net Revenue: 1 445 M
- EBITDA: -168 759 008
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-11-13
- EPS/Forecast: -0.092
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
P3 Health Partners Inc News
New
P3 Health Partners Schedules Fourth Quarter and Full Year 2025 Earnings Release and Conference Call
HENDERSON, Nev., March 13, 2026--(BUSINESS WIRE)--P3 Health Partners Inc. ("P3" or the "Company") (NASDAQ: PIII), a patient-centered and physician-led population health management company, today annou...
How Recent Developments Are Reframing The P3 Health Partners (PIII) Investment Story
The recent move to a reduced US$12.50 price target for P3 Health Partners, alongside an unchanged fair value estimate of US$10.25, signals a recalibration of expectations rather than a rewrite of the ...
Why The Narrative Around P3 Health Partners Is Shifting After Recent Q3 Weakness And Outlook Reset
P3 Health Partners has seen its price target revised to $12.50 even as fair value per share holds steady at $10.25 and the discount rate remains fixed at 12.5%. This underscores a more nuanced narrati...
What The Latest Outlook Shift Means For P3 Health Partners Valuation
P3 Health Partners has seen its price target recalibrated, even as the core assumptions behind its fair value of $10.25 per share, the 12.5% discount rate, and roughly 6.1% revenue growth remain effec...
Or get access to advanced financial data starting only $19.99
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.